Cancer is cruel. It doesn’t care that you’re only 37, that you're the mother of a little girl who is your entire world. So Elissa vowed to fight.

"It's hours and hours of activity that's required. I just asked the question: Could that be any easier?" researcher Lise ...

Past research has shown that vitamin D supports nerve growth and reduces inflammation, both of which are important for ...

FDA approves Zynyz for advanced anal cancer, marking a breakthrough for the 10,000 diagnosed annually—including actress ...

Summer break is just around the corner, and for families with kids, that usually means vacations, picnics at the park, and ...

In a new study, patients with early-stage breast cancer linked to BRCA1 and BRCA2 gene mutations showed remarkable survival ...

FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.

For patients with EGFR-mutated NSCLC, treatment options in the frontline include osimertinib monotherapy, amivantamab with ...

The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

Hepatic artery infusion (HAI) therapy offers a new approach for people whose colorectal cancer has spread to the liver. It ...

Immune checkpoint inhibitors, such as Opdivo (nivolumab) and Keytruda (pembrolizumab), have been a huge advance in the ...

PD-1 antibody was approved as first-line treatment for locally recurrent or metastatic squamous cell anal carcinoma.